The effect of self-efficacy enhancement program on medication adherence
Phase 3
Recruiting
- Conditions
- Acute coronary syndrome.Chronic ischaemic heart disease, unspecified
- Registration Number
- IRCT20180623040204N1
- Lead Sponsor
- Shahroud University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Being at the age of 20 or over
Ability to speak and understand Persian language
diagnosis of Acute coronary syndrome by a cardiologist.
Exclusion Criteria
Treatment-resistant ventricular arrhythmia and cardiojenic shock following illness
having a history of cognitive impairment or known anxiety disorders based on patient's history and self-declaration and doctor's approval
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Medication adherence score in self-efficacy for Appropriate Medication Use Scale (SEAMS). Timepoint: medication adherence measurement as soon as the patient's condition improves. It is done before the intervention and 40 days after the intervention. Method of measurement: Self-Efficacy for Appropriate Medication Use Scale.
- Secondary Outcome Measures
Name Time Method